Estradiol levels are altered in human immunodeficiency virus-infected pregnant women randomized to efavirenz-vs lopinavir/ritonavir-based antiretroviral therapy
Clinical Infectious Diseases Dec 17, 2017
McDonald CR, et al. - The authors performed an analysis of longitudinal progesterone and estradiol levels in pregnancy, among human immunodeficiency virus (HIV)–infected pregnant women who were randomized to efavirenz (EFV)-vs lopinavir/ritonavir (LPV/r)-based antiretroviral therapy (ART). In pregnancy, combination ART regimens differentially influenced estradiol levels, which served as a hormone critical to the maintenance of a healthy pregnancy. Identifying Combination antiretroviral therapy (cART) regimens that minimize perinatal HIV transmission without contributing to hormonal dysregulation represented an urgent public health priority.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries